Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
41
GGAL Quote, Financials, Valuation and Earnings
Last price:
$47.72
Seasonality move
:
5.21%
Day range:
$46.02 - $47.80
52-week range:
$23.53 - $74.00
Dividend yield:
5.07%
P/E ratio:
5.21x
P/S ratio:
1.01x
P/B ratio:
1.18x
Volume:
1.4M
Avg. volume:
1.5M
1-year change:
62.11%
Market cap:
$7.4B
Revenue:
$8.3B
EPS (TTM):
$8.90
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.7B | $18.6B | $36.9B | $27.8B | $8.3B | |
| Revenue Growth (YoY) | 27.36% | 117.53% | 98.33% | -24.66% | -70.26% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4B | $4.7B | $8B | $4.3B | $1.6B | |
| Other Inc / (Exp) | $2.9B | $6.1B | $18.1B | $2.6B | $1.2B | |
| Operating Expenses | $2.7B | $5.6B | $9.5B | $5B | $1.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.9B | $3B | $3.5B | $4.5B | $2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $874.4M | $1.1B | $906.6M | $1.7B | $644.5M | |
| Net Income to Company | $1.9B | $3B | $3.5B | $4.5B | $2.4B | |
| Minority Interest in Earnings | -$14.3M | -- | -$480 | $20.9K | $148.6K | |
| Net Income to Common Excl Extra Items | $1.1B | $2B | $2.6B | $2.8B | $1.8B | |
| Basic EPS (Cont. Ops) | $7.34 | $13.46 | $17.56 | $18.93 | $12.01 | |
| Diluted EPS (Cont. Ops) | $7.34 | $13.46 | $17.56 | $18.93 | $12.01 | |
| Weighted Average Basic Share | $144.3M | $147.8M | $147.8M | $147.8M | $148.6M | |
| Weighted Average Diluted Share | $144.3M | $147.8M | $147.8M | $147.8M | $148.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.8B | $14.7B | $33.7B | $29.7B | $5.8B | |
| Revenue (Reported) | $8.7B | $18.6B | $36.9B | $27.8B | $8.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.8B | $14.7B | $33.7B | $29.7B | $5.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $652M | $1.9B | $5.2B | $3.5B | $1.7B | |
| Revenue Growth (YoY) | -35.32% | 189.01% | 178.16% | -33.62% | -50.12% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $216.4M | $509.7M | $1.1B | $352.8M | $365.4M | |
| Other Inc / (Exp) | $203.9M | $704.1M | $1.1B | $401.5M | $237M | |
| Operating Expenses | $51.8M | -$136.2M | $1.3B | $407.7M | $424.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $56M | $162.1M | $574.9M | $703.3M | $223.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29.1M | $62.4M | $207.1M | $240.3M | $68.8M | |
| Net Income to Company | -- | -- | -- | $703.3M | $223.1M | |
| Minority Interest in Earnings | -- | -- | -- | $196.4K | -$46.1K | |
| Net Income to Common Excl Extra Items | $26.9M | $99.7M | $367.8M | $463.2M | $154.2M | |
| Basic EPS (Cont. Ops) | $0.18 | $0.68 | $2.49 | $3.14 | $0.97 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.68 | $2.49 | $3.14 | $0.97 | |
| Weighted Average Basic Share | $147.5M | $147.5M | $147.9M | $147.5M | $159.8M | |
| Weighted Average Diluted Share | $147.5M | $147.5M | $147.9M | $147.5M | $159.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $455.1M | $162.1M | $574.9M | $2.3B | $887.3M | |
| Revenue (Reported) | $652M | $1.9B | $5.2B | $3.5B | $1.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $455.1M | $162.1M | $574.9M | $2.3B | $887.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $18.9B | $34B | $22.2B | $7.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1B | $4.8B | $7.4B | $3.3B | $1.7B | |
| Other Inc / (Exp) | $1.1B | $6.3B | $15.3B | $1.7B | $1B | |
| Operating Expenses | $548.3M | $4.6B | $6.7B | $1.8B | $1.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $591.9M | $3B | $3.3B | $4B | $2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $290M | $1B | $892.3M | $1.4B | $491.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$1.3M | -- | -- | $210.4K | -$56.8K | |
| Net Income to Common Excl Extra Items | $304.7M | $2B | $2.4B | $2.5B | $1.5B | |
| Basic EPS (Cont. Ops) | $2.12 | $2.64 | $16.20 | $14.60 | $8.90 | |
| Diluted EPS (Cont. Ops) | $2.12 | $2.64 | $16.20 | $14.60 | $8.90 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.1B | $13.6B | $3.3B | $16.5B | $4B | |
| Revenue (Reported) | $3.4B | $18.9B | $34B | $22.2B | $7.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.1B | $13.6B | $3.3B | $16.5B | $4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $652M | $1.9B | $5.2B | $3.5B | $1.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $216.4M | $509.7M | $1.1B | $352.8M | $365.4M | |
| Other Inc / (Exp) | $203.9M | $704.1M | $1.1B | $401.5M | $237M | |
| Operating Expenses | $51.8M | -$136.2M | $1.3B | $407.7M | $424.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $56M | $162.1M | $574.9M | $703.3M | $223.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29.1M | $62.4M | $207.1M | $240.3M | $68.8M | |
| Net Income to Company | -- | -- | -- | $703.3M | $223.1M | |
| Minority Interest in Earnings | -- | -- | -- | $196.4K | -$46.1K | |
| Net Income to Common Excl Extra Items | $26.9M | $99.7M | $367.8M | $463.2M | $154.2M | |
| Basic EPS (Cont. Ops) | $0.18 | $0.68 | $2.49 | $3.14 | $0.97 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.68 | $2.49 | $3.14 | $0.97 | |
| Weighted Average Basic Share | $147.5M | $147.5M | $147.9M | $147.5M | $159.8M | |
| Weighted Average Diluted Share | $147.5M | $147.5M | $147.9M | $147.5M | $159.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $455.1M | $162.1M | $574.9M | $2.3B | $887.3M | |
| Revenue (Reported) | $652M | $1.9B | $5.2B | $3.5B | $1.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $455.1M | $162.1M | $574.9M | $2.3B | $887.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.1B | $4.5B | $7.9B | $5.4B | $6.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $424.2M | $584.4M | $987M | $481.3M | $460.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $50.8M | $97.4M | $187.3M | $87.8M | $108.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $7.5B | $13.1B | $17.6B | $11.4B | $12.4B | |
| Property Plant And Equipment | $784.4M | $1.2B | $2B | $955.4M | $965.7M | |
| Long-Term Investments | $3.4B | $6.4B | $20.7B | $7B | $6.2B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $259.5M | $402.7M | $680M | $332.4M | $295.4M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $18.9B | $31.8B | $59.5B | $27.5B | $31.5B | |
| Accounts Payable | -- | -- | $793M | $388.5M | $228.5M | |
| Accrued Expenses | -- | $169.1M | $319.1M | $211.1M | $209.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $717.9M | $1.6B | $3.3B | $2.1B | $1.6B | |
| Long-Term Debt | $942.4M | $1.5B | $2.6B | $1.2B | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $15.7B | $26.1B | $48.7B | $22B | $25.7B | |
| Common Stock | $17.5M | $14.4M | $8.4M | $1.8M | $1.5M | |
| Other Common Equity Adj | $3.2B | $4.6B | $8.8B | $4B | $3.3B | |
| Common Equity | $3.3B | $5.8B | $10.7B | $5.4B | $5.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $60 | $100 | $340 | $238.6K | $153.7K | |
| Total Equity | $3.3B | $5.8B | $10.7B | $5.4B | $5.9B | |
| Total Liabilities and Equity | $18.9B | $31.8B | $59.5B | $27.5B | $31.5B | |
| Cash and Short Terms | $3.1B | $4.5B | $7.9B | $5.4B | $6.5B | |
| Total Debt | $942.4M | $1.5B | $2.6B | $1.2B | $1.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | -- | $2.4B | $2.5B | $5.8B | |
| Short Term Investments | -- | -- | -- | -- | $2.7B | |
| Accounts Receivable, Net | -- | -- | -- | -- | $575.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2.4B | -- | $2.4B | $2.5B | $15.3B | |
| Property Plant And Equipment | $533.3M | -- | $670.2M | $634.6M | $1B | |
| Long-Term Investments | $3.5B | -- | $7.7B | $6.4B | $6.2B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | $302.1M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $12.8B | -- | $18.2B | $15.6B | $32.7B | |
| Accounts Payable | -- | -- | -- | -- | $208.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $1.5B | |
| Long-Term Debt | $637.6M | -- | $795.8M | $630.8M | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $10.5B | -- | $14.6B | $11.7B | $26.3B | |
| Common Stock | -- | -- | -- | -- | $1.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | $3.3B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $205.4K | |
| Total Equity | $2.2B | -- | $3.6B | $3.9B | $6.3B | |
| Total Liabilities and Equity | $12.8B | -- | $18.2B | $15.6B | $32.7B | |
| Cash and Short Terms | $2.4B | -- | $2.4B | $2.5B | $8.4B | |
| Total Debt | $637.6M | -- | $795.8M | $630.8M | $1.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | $3B | $3.5B | $4.5B | $2.4B | |
| Depreciation & Amoritzation | $348.5M | $927.8M | $1.5B | $699.4M | $206.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.7B | $18.1B | $30.8B | $13.8B | $3.8B | |
| Capital Expenditures | $299.7M | $636.3M | $990M | $614.3M | $235.9M | |
| Cash Acquisitions | -$4.3M | -$10.5M | -$41.5M | -$113.5M | $1.2B | |
| Cash From Investing | -$285.3M | -$538.7M | -$999.1M | -$679.4M | $950.6M | |
| Dividends Paid (Ex Special Dividend) | -$85.7M | -$123.3M | -$1.1B | -$1.5B | -$675.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $3B | $7.6B | $3.7B | $2.3B | |
| Long-Term Debt Repaid | -$2.7B | -$2.3B | -$5B | -$4.1B | -$1.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$1.1M | |
| Cash From Financing | -$1.5B | $539.4M | $1.4B | -$1.9B | $454.4M | |
| Beginning Cash (CF) | $13.3B | $36.6B | $66.8B | $34.3B | $7.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6B | $18.1B | $31.2B | $11.3B | $5.3B | |
| Ending Cash (CF) | $15.9B | $41.1B | $70.9B | $27.1B | $8.1B | |
| Levered Free Cash Flow | $7.4B | $17.5B | $29.8B | $13.2B | $3.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $703.3M | $223.1M | |
| Depreciation & Amoritzation | -- | -- | -- | $54.9M | $58.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $2.1B | -$1B | |
| Capital Expenditures | -- | -- | -- | $65.5M | $95.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$63.7M | -$68.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | $76.3K | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $417.7M | $511.6M | |
| Long-Term Debt Repaid | -- | -- | -- | -$355.3M | -$454.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $62.5M | $155.5M | |
| Beginning Cash (CF) | -- | -- | -- | $9.3B | $7.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $100.5M | $193.7M | |
| Additions / Reductions | -- | -- | -- | $2.1B | -$931.2M | |
| Ending Cash (CF) | -- | -- | -- | $7.9B | $6.4B | |
| Levered Free Cash Flow | -- | -- | -- | $2B | -$1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | $368.6M | $238.7M | |
| Cash Acquisitions | -- | -- | -- | -$9.4M | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$1.2B | -$605.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | $11.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $703.3M | $223.1M | |
| Depreciation & Amoritzation | -- | -- | -- | $54.9M | $58.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $2.1B | -$1B | |
| Capital Expenditures | -- | -- | -- | $65.5M | $95.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$63.7M | -$68.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | $76.3K | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $417.7M | $511.6M | |
| Long-Term Debt Repaid | -- | -- | -- | -$355.3M | -$454.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $62.5M | $155.5M | |
| Beginning Cash (CF) | -- | -- | -- | $9.3B | $7.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $100.5M | $193.7M | |
| Additions / Reductions | -- | -- | -- | $2.1B | -$931.2M | |
| Ending Cash (CF) | -- | -- | -- | $7.9B | $6.4B | |
| Levered Free Cash Flow | -- | -- | -- | $2B | -$1.1B | |
Get GGAL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GGAL
Sector
P/E ratio
5.21x
12.18x
PEG ratio
0.02x
0.40x
P/B ratio
1.18x
1.10x
Price / LTM sales
1.01x
2.66x
Growth Metrics
GGAL
Sector
Revenue growth
-50.12%
5.1%
Earnings growth
-69.28%
2.61%
Revenue (5-year growth)
4.36%
5.17%
Earnings forecast
$1.00
$0.61
Profitability
GGAL
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
24.18%
5.2%
Return on assets
5.96%
0.97%
Return on equity
29.43%
9.24%
Earnings Date
Last Earnings Date
May
27
Next Earnings Date
Aug
22
Estimated Next Earnings Date
Aug
26
Balance Sheet
GGAL
Sector
Total cash
$8.4B
$452M
Short term investments
--
$220.9M
Total assets
$31.5B
$3.8B
Long term debt
$1.7B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
